American Board of Pathology (ABPath) · ABPath Pediatric Pathology Exam Blueprint, marked Updated for 2026, and currently linked final Pediatric Pathology Content Specifications dated 2025-10-13; verified on 2026-10-09. Neither document states a separate day-level effective date. The workbook label American Board of Pathology - Subspecialty in Pediatric Pathology maps to this examination; the assigned canonical slug is preserved.

This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.

• Pediatric Pathology — ABPath
• Pediatric Pathology Exam Blueprint — Updated for 2026
• Pediatric Pathology Content Specifications
• Content Specifications for Examinations — ABPath
• Subspecialty Exam Blueprints and Daily Schedules — ABPath
• ABPath Virtual Microscopy Samples
• Placental acute inflammation infiltrates and pregnancy outcomes: a retrospective cohort study
• Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping
• Neonatal Survival After Serial Amnioinfusions for Bilateral Renal Agenesis: The RAFT Trial
• Necrotizing Enterocolitis Surgery Trial Protocol
• Necrotizing Enterocolitis — NICHD
• Clinical Overview of CMV and Congenital CMV — CDC
• Tetralogy of Fallot — CDC
• Newborn Breathing Conditions: Respiratory Distress Syndrome — NHLBI
• Childhood Medulloblastoma and Other CNS Embryonal Tumors — NCI PDQ
• Updated ERNICA guidelines for rectosigmoid Hirschsprung's disease 2025
• Guideline for the Evaluation of Cholestatic Jaundice in Infants — NASPGHAN/ESPGHAN
• Wilms Tumor and Other Childhood Kidney Tumors — NCI PDQ
• Childhood Acute Lymphoblastic Leukemia — NCI PDQ
• Childhood Soft Tissue Sarcoma — NCI PDQ
• Ewing Sarcoma — NCI PDQ
• Fluorescence In Situ Hybridization — NHGRI
• Pompe Disease: Diagnosis and Management — Canadian Expert Panel
• Neuroblastoma — NCI PDQ
• GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas
• Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency — Endocrine Society Guideline
• Principles of Analytic Validation of Immunohistochemical Assays — CAP
• Retinoblastoma — NCI PDQ
• About SUID and SIDS — CDC
• Client Challenge
• Acute Myeloid Leukemia Treatment (PDQ®) - NCI
• HLH-2004_ORIGINAL.pdf
• Osteosarcoma and UPS of Bone Treatment - NCI
• bjog-2018-jauniaux-placenta-praevia-and-placenta-accreta-diagnos.pdf
• Society for Maternal-Fetal Medicine Consult Series #75: Evaluation and management of non-immune hydrops fetalis - SMFM Publications and Clinical Guidelines
• Appendix C | Surveillance Manual | Birth Defects | NCBDDD | CDC
• Client Challenge
• Kidney.Wilms_4.4.1.0.REL_CAPCP.pdf
• Childhood Acute Myeloid Leukemia Treatment (PDQ®) - NCI
• Society for Maternal-Fetal Medicine Consult Series #74:Cell-free DNA screening for aneuploidies: Updated guidance - SMFM Publications and Clinical Guidelines